Astal Laboratories Limited

Equities

MACINTR

INE307N01014

Market Closed - Bombay S.E. Other stock markets 03:30:58 27/06/2024 pm IST			5-day change	1st Jan Change
52.15 ^INR	+4.99%		+15.73%	+47.61%

25/05	Astal Laboratories Limited Appoints BIRENDRAKUMAR SAHOO as Additional Non-Executive Independent Director	CI
24/05	Astal Laboratories Limited Announces Change in Corporate Office Address	CI

Astal Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024

May 24, 2024 at 07:58 pm IST

Astal Laboratories Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported revenue was INR 236.61 million compared to INR 36.07 million a year ago. Net income was INR 7.85 million compared to INR 0.164 million a year ago.

Latest news about Astal Laboratories Limited

Astal Laboratories Limited Appoints BIRENDRAKUMAR SAHOO as Additional Non-Executive Independent Director	25/05	CI
Astal Laboratories Limited Announces Change in Corporate Office Address	24/05	CI
Astal Laboratories Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	24/05	CI
Astal Laboratories Limited Reports Earnings Results for the Full Year Ended March 31, 2024	24/05	CI
Macro International Changes Company Name to Astal Laboratories	23/04	MT
Macro International Limited has Changed its Name to ASTAL LABORATORIES LIMITED	22/04	CI
Macro International Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02	CI
Macro International Limited announced that it expects to receive INR 147.48 million in funding	20/12	CI
Macro International Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	10/11	CI
Macro International Limited Announces Fine from BSE	13/23/13	CI
Macro International Limited announced that it has received INR 26.6 million in funding	13/23/13	CI
Macro International Limited Approves Change in Directorate	20/23/20	CI
Macro International Limited announced that it expects to receive INR 26.6 million in funding	18/23/18	CI
Macro International Enters Contract Media Business	25/23/25	MT
Macro International Limited Ventures into Contrast Media Business, Introduces Lopromide USP for Bulk Drug Manufacturing	24/23/24	CI
Macro International Limited Approves Appointment of Mr. Radhakishore Pandrangi as Additional Non-Executive Independent Director, Chairperson of Audit Committee, Member of Stakeholders Relationship Committee, Nomination & Remuneration Committee	18/23/18	CI
Macro International's CEO, CFO Resign	17/23/17	MT
Macro International Limited Appoints Balayogiswara Rao Peddinti as Chief Financial Officer	15/23/15	CI
Macro International Limited Announces Resignation of Mr. Lakshmi Narasimha Anand Kumar Kanuparthi as Additional Non-Executive Director	15/23/15	CI
Macro International Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	15/23/15	CI
Macro International's CEO, CFO Resign	20/23/20	MT
Macro International Limited Announces Resignation of Mr. Kommera Harish as Chief Executive Officer	19/23/19	CI
Macro International Limited Announces Resignation of Mr. Sesha Sai Nikhil Chintalapati as Chief Financial Officer	19/23/19	CI
Macro International Limited Announces Resignation of Birendrakumar Sahoo as Independent Non-Executive Director	19/23/19	CI
Macro International Limited Announces Board Appointments	10/23/10	CI